Assessing the Efficacy of Alkylating Agent Regimens in the Treatment of Infantile Malignant Osteopetrosis: Cyclophosphamide, Busulfan, or Thiotepa
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.